Corporate

Newark, Delaware, June 18, 2019 – QPS, a global contract research organization (CRO) providing discovery, preclinical and clinical drug development services, today announced continuing growth in Asia, a region that is fast becoming a robust biotech and pharmaceutical research hub. With all eyes on Asia, QPS hosted a 28-member delegation from Taiwan at its headquarters […]

Newark, Delaware, January 8, 2019 – The year 2019 marks 24 years of growth for QPS, LLC, a leading global CRO focused on bioanalytics and clinical trials that accelerate pharmaceutical breakthroughs. Today, the company announced the launch of a new brand identity to support continued global expansion. Since its inception in 1995, the company has

QPS Neuro and Pronexus Analytical announced formation of a joint partnership aiming to build their respective areas of expertise on unified experimental platforms and offer a broader suite of services to their clients. The effects of test compounds can be now evaluated from in vitro screening tests in cell cultures to in vivo studies in

New, five-year facility offers greater financial flexibility QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, has preemptively negotiated a new senior credit facility with a lending group comprised of three leading US financial institutions. The senior credit facility closed on March 9,

Complementary world-class capabilities prime for accelerating cardiovascular drug development QPS Holdings LLC and G-CURE BV announce today that they have signed an agreement to collaborate in executing cardiovascular drug development programs for pharmaceutical companies. The proposed collaboration focuses on cardiovascular research areas where G-CURE has extensive expertise. The aim is to move promising drug candidates

Nomination a by-product of employee, client, vendor and community support Dr. Benjamin Chien, CEO of QPS Holdings, LLC, a leading full-service GLP/GCP-compliant contract research organization providing testing services to support preclinical and clinical research and development, has been named a finalist for the prestigious EY Entrepreneur Of The Year® 2016 Award in Greater Philadelphia. For

Agreement aims to advance the hybrid LBA-LCMS workflow for biologics quantification SCIEX, a global leader in life science analytical technologies, and QPS Holdings, LLC (QPS), a leading global full-service Contract Research Organization (CRO), today announced a collaboration to advance Hybrid LBA – LCMS, a workflow for routine biologics quantification. Under the agreement, QPS Holdings will

Agreement solidifies cell supply partnership for the production, characterization and distribution of primary human liver cells including hepatocytes and hepatic stellate cells Hepatic Biosciences, a division of QPS Holdings, LLC, a U.S.-headquartered contract research organization and cell products manufacturer, and Samsara Sciences (“Samsara”), a provider of specialized human liver cells for research use, announced today